Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 212 publications
Mosunetuzumab With Response-Adapted Polatuzumab Vedotin and Obinutuzumab in Untreated Indolent B-Cell Non-Hodgkin Lymphoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 14, 2026
Pharmacologic activity, safety, and preliminary efficacy of GEN3009, a CD37-targeting DuoHexaBody, in relapsed or refractory B-cell non-Hodgkin's lymphoma.
Journal: Journal for immunotherapy of cancer
Published: June 10, 2026
Impact of doublet post-transplant maintenance on outcomes in multiple myeloma: A propensity score matching analysis.
Journal: Bone marrow transplantation
Published: April 01, 2026
"Immunologic dream team": BiTEs periallotransplant to redirect donor lymphocytes toward GVL.
Journal: Blood advances
Published: March 30, 2026
Outcomes From the Multicenter ACCRU-LY-1804/CARiBOU TRIAL (Cytarabine, Acalabrutinib and Rituximab Integrated With Bortezomib-Based Outpatient Therapy) in 1st Line Mantle Cell Lymphoma.
Journal: American journal of hematology
Published: March 25, 2026
Pharma steps back from Hodgkin lymphoma: now what?
Journal: Blood advances
Published: December 09, 2025
Biomarkers Informed by Single-Cell and Spatial Transcriptomics-Biomarkers for Grade 3 Follicular Lymphoma.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: November 04, 2025
Bispecific antibodies in action: the reality of engagement.
Journal: Blood
Published: October 30, 2025
HIV, HBV, and HCV Testing in Newly Diagnosed Diffuse Large B-Cell Lymphoma: Experience From a Comprehensive Cancer Center.
Journal: Clinical lymphoma, myeloma & leukemia
Published: September 25, 2025
Barriers to Investigator-Initiated Clinical Trial Enrollment in Frontline Large B-Cell Lymphoma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: September 14, 2025
Last Updated: 09/26/2026